Reduced Expression of P27 Is a Novel Mechanism of Docetaxel Resistance in Breast Cancer Cells

Breast Cancer Research - United Kingdom
doi 10.1186/bcr918
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Loss of PEDF: A Novel Mechanism of Antihormone Resistance in Breast Cancer

2013English

Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2010English

Differentiation-State Plasticity Is a Targetable Resistance Mechanism in Basal-Like Breast Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL

Cancer Research
Cancer ResearchOncology
2009English

D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

Surface TRAIL Decoy Receptor-4 Expression Is Correlated With TRAIL Resistance in McF7 Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Loss of Pigment Epithelium-Derived Factor: A Novel Mechanism for the Development of Endocrine Resistance in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2012English

miR-34a Expression in Human Breast Cancer Is Associated With Drug Resistance

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy